50
Participants
Start Date
December 1, 2023
Primary Completion Date
August 7, 2024
Study Completion Date
August 7, 2024
Neostigmine with glycopyrrolate
Administration by intravenous infusion
Sugammadex
Administration by intravenous infusion
Cleveland Clinic, Cleveland
The Cleveland Clinic
OTHER